Skip to content

Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain

CompletedPhase 2NCT00524420
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

While acute pain after surgery or trauma comes on suddenly and lasts for a limited amount of time, chronic pain persists and can continue for months and even years. Repetitive transcranial magnetic stimulation (rTMS) uses a magnetic field to deliver a current to the brain and can affect brain activity. The purpose of this study is to determine the effectiveness of rTMS treatment in reducing chronic widespread pain in women.

Study details

Official title
Transcranial Magnetic Stimulation (TMS) in the Treatment of Chronic Widespread Pain (CWP)
Sponsor
University of Washington
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Start date
2008-02
Primary completion
2010-12
Sex
Female
Age range
from 18 Years to 65 Years
Results posted
Yes, on ClinicalTrials.gov
Countries
United States
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Diagnosis of chronic widespread pain as defined by the 1990 American College of Rheumatology guidelines: chronic musculoskeletal pain for at least 3 months; pain above and below the waist; pain on both right and left sides; pain at one axial site (e.g., head, neck, spine, or back) * Willing to remain on a stable medical regimen during the entire 6-week course of Phase 1 treatment and 8 weeks prior to rTMS treatment * Willing to undergo random assignment and able to attend treatment sessions * Willing to remain on a stable psychotherapy regimen if currently receiving psychotherapy that has been ongoing for at least 3 months prior to study entry Exclusion Criteria: * Unable to maintain treatment as usual at stable doses for any medical or psychiatric conditions for 8 weeks prior to and during the study * Another medical condition associated with significant pain (e.g., diabetic neuropathy, systemic lupus erythematosus, Rheumatoid arthritis, severe degenerative joint disease) * Any condition that might increase the risk of seizures from TMS * History of a seizure disorder or family history of a seizure disorder * Previous use of TMS * Involvement in litigation or disability that is related to fibromyalgia, chronic widespread pain, or depression * Current use of proconvulsant medications (e.g., bupropion) * Metal in the body that would prevent magnetic resonance imaging (MRI) or TMS (e.g., aneurysm clips, pacemakers, neurostimulators) * History of head injury associated with loss of consciousness for more than 15 minutes, brain surgery, or lithium toxicity * History of bipolar disorder, schizophrenia, obsessive compulsive disorder, panic disorder, or post-traumatic stress disorder * Current substance abuse or dependence * Active suicidal intent or plan * Severe claustrophobia that would prevent MRI * Major depression with psychotic features or a current major depressive episode lasting longer than 5 years * Pregnant

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00524420